title: Switching patients from clopidogrel to novel P2Y12 receptor inhibitors in acute coronary syndrome: comparative effects of prasugrel and ticagrelor on platelet reactivity.
authors.affiliation: Department of Cardiology, CHU de Toulouse and Université Paul Sabatier, Toulouse, France; INSERM U1048, I2MC and Université Paul Sabatier, Toulouse, France. Electronic address: t.lhermusier@gmail.com.
authors.forename: T
authors.initials: T
authors.lastname: Lhermusier
authors.affiliation: Laboratory of Hematology, CHU de Toulouse and Université Paul Sabatier, Toulouse, France.
authors.forename: S
authors.initials: S
authors.lastname: Voisin
authors.affiliation: Department of Cardiology, CHU de Toulouse and Université Paul Sabatier, Toulouse, France.
authors.forename: G
authors.initials: G
authors.lastname: Murat
authors.affiliation: Department of Cardiology, CHU de Toulouse and Université Paul Sabatier, Toulouse, France.
authors.forename: S
authors.initials: S
authors.lastname: Mejean
authors.affiliation: Laboratory of Hematology, CHU de Toulouse and Université Paul Sabatier, Toulouse, France; INSERM U1048, I2MC and Université Paul Sabatier, Toulouse, France.
authors.forename: C
authors.initials: C
authors.lastname: Garcia
authors.affiliation: Department of Cardiology, CHU de Toulouse and Université Paul Sabatier, Toulouse, France.
authors.forename: V
authors.initials: V
authors.lastname: Bataille
authors.affiliation: Department of Cardiology, MedStar Washington Hospital Center, Washington, DC, United States.
authors.forename: M J
authors.initials: MJ
authors.lastname: Lipinski
authors.affiliation: Department of Cardiology, CHU de Toulouse and Université Paul Sabatier, Toulouse, France.
authors.forename: D
authors.initials: D
authors.lastname: Carrié
authors.affiliation: Laboratory of Hematology, CHU de Toulouse and Université Paul Sabatier, Toulouse, France; INSERM U1048, I2MC and Université Paul Sabatier, Toulouse, France.
authors.forename: P
authors.initials: P
authors.lastname: Sié
mesh_terms: D054058:Acute Coronary Syndrome / Q000097:blood / Q000188:drug therapy*; D000241:Adenosine / Q000008:administration & dosage / Q000031:analogs & derivatives*; D000368:Aged; D001792:Blood Platelets / Q000187:drug effects* / Q000378:metabolism; D000077144:Clopidogrel; D057915:Drug Substitution / Q000379:methods*; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D010879:Piperazines / Q000008:administration & dosage*; D000068799:Prasugrel Hydrochloride; D011446:Prospective Studies; D058921:Purinergic P2Y Receptor Antagonists / Q000008:administration & dosage*; D013876:Thiophenes / Q000008:administration & dosage*; D000077486:Ticagrelor; D013988:Ticlopidine / Q000008:administration & dosage / Q000031:analogs & derivatives*; D016896:Treatment Outcome
chemical_list: D010879:Piperazines; D058921:Purinergic P2Y Receptor Antagonists; D013876:Thiophenes; D000077144:Clopidogrel; D000068799:Prasugrel Hydrochloride; D000077486:Ticagrelor; D000241:Adenosine; D013988:Ticlopidine
keywords: Acute coronary syndrome; Clopidogrel; Platelet reactivity; Prasugrel; Ticagrelor